Latest filing published 27 Jun 2024 for IDEAYA Biosciences, Inc., €80k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Jason Throne in IDEAYA Biosciences, Inc., where the filings describe the role as board member. Between 4 June 2020 and 27 June 2024, the trades on record add up to 36 filings.
Every open-market trade on record is a sale: 19 sales worth €1.5M. The rest of the record consists of 17 option exercises.
The record was last updated on 27 June 2024 with an option exercise (€308k) in IDEAYA Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations